VP’s broaden responsibilities at Shire
David Colpman
Ann Judge
Ann Judge

News

VP’s broaden responsibilities at Shire

26 Jul, 2012

Published over 14 years ago. See the latest and most current information on News.

Shire plc, a specialty biopharmaceutical company has announced promotion of two senior leaders; David Colpman Senior Vice President, will assume responsibility for leading the company’s global Business Development team, following the retirement of Barbara Deptula, former Executive Vice President and Chief Corporate Development Officer.

With over 12 years of experience with Shire where he has been the lead on many of Shire’s significant deals, David worked at Glaxo Wellcome, Novo Nordisk and Boots Pharmaceuticals in a variety of business development and commercial roles. He is a member of the Royal Pharmaceutical Society and began his industry career at ICI (now AstraZeneca) in formulation and manufacturing. David will report to Shire Chief Executive, Angus Russell.

Ann Judge, Senior Vice President of Shire’s global Human Resources (HR) team has joined the Shire Leadership Team. Ann has over 20 years of global HR experience in the pharmaceutical, chemical, and oil and gas industries, having begun her career with Dow Chemical. She lived and worked in Germany in the late1990s and relocated to Switzerland in early 2000s, where she also supported the commercial Asia Pacific Region. Ann joined to lead the global HR team at Shire in late 2010, after six years with Wyeth Pharmaceuticals.

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Direct mercury analysis: Weighing the cost and productivity benefits
Explore more Arrow
Pollution Solutions Online
Vacuum technology enables efficient lithium-ion battery recycling with recovery rates of up to 95%
Explore more Arrow
Petro Online
The expanding role of high-temperature, high-shear viscometry in modern engine oil development
Explore more Arrow
Chromatography Today
Bacterial enzyme discovery reveals novel route to study antimicrobial resistance
Explore more Arrow